Immediate Impact
54 standout
Citing Papers
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
Understanding and targeting resistance mechanisms in cancer
2023 Standout
Works of Luigi Bortolotti being referenced
Treating disease progression with osimertinib in EGFR-mutated non-small-cell lung cancer: novel targeted agents and combination strategies
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Luigi Bortolotti | 553 | 116 | 201 | 267 | 28 | 850 | |
| Federico Davini | 642 | 150 | 233 | 202 | 56 | 941 | |
| Mi Kyung Bae | 462 | 288 | 201 | 184 | 29 | 805 | |
| Naoto Miyazawa | 430 | 317 | 245 | 174 | 46 | 942 | |
| Costante Ricci | 465 | 135 | 300 | 440 | 27 | 959 | |
| Minoru Kamata | 305 | 289 | 321 | 158 | 48 | 770 | |
| David Simansky | 537 | 253 | 400 | 154 | 42 | 1.1k | |
| Sandro Massimo Priola | 263 | 48 | 200 | 353 | 39 | 794 | |
| N.M.C. So | 296 | 116 | 194 | 70 | 29 | 848 | |
| Philippe Dartevelle | 797 | 82 | 214 | 73 | 40 | 1.1k | |
| Alfred D. Katz | 255 | 223 | 544 | 156 | 35 | 1.0k |
All Works
Loading papers...